Register Enables Compliance and Tracking for Post-Merger Global Pharma

An Asia-headquartered pharma company (~10,000 employees) struggled post-merger with regulatory tracking and compliance, lacking defined workflows, sufficient data entry, and timely tracking -- delays in cross-team requests were pushing back product launches. After an RFP that narrowed eight vendors to four finalists, the company chose ArisGlobal's Register, partly on its parent company's prior positive experience and Register's broader functionality and process visibility. The company achieved its compliance goals with greater cross-geography product oversight, made Regulatory Affairs the 'single source of truth' for supply chain, manufacturing, pharmacovigilance, medical affairs and finance, integrated PSUR planning into compliance reporting, and increased organization-wide visibility. The customer said 'ArisGlobal represents a partner, not just a vendor.' No numerical efficiency or cost metrics are given.

The customer is anonymised in ArisGlobal’s own case study — not withheld by us.

ArisGlobal makes the LifeSphere suite — safety-case management, signal detection and clinical systems used by pharmacovigilance and clinical-operations teams.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.